基本資料
個股的基本資料,以及所屬的類股和產業。
公司介紹
業務介紹
艾博集團公司主要為美容、個人護理、家居護理、處方藥、消費者健康護理、注射劑以及食品和飲料市場提供分配、密封和材料科學解決方案。該公司通過三個業務部門運營:製藥、美容+家居和食品+飲料。製藥部門為鼻過敏治療提供泵浦;為哮喘和慢性阻塞性肺病等呼吸系統疾病提供計量吸入劑閥門;為注射劑主要包裝組件提供彈性體;以及提供主動材料科學解決方案。美容+家居部門主要向個人護理和家居護理市場銷售泵浦、蓋子、氣霧閥、配件和密封解決方案;向美容市場銷售泵浦和裝飾組件。食品+飲料部門為食品和飲料市場提供分配和非分配蓋子、彈性流體控制組件、噴霧泵和氣霧閥。該公司通過自有銷售團隊以及獨立代表和經銷商在亞洲、歐洲、拉丁美洲和北美銷售其產品。該公司與PureCycle Technologies LLC有戰略合作關係,共同開發超純再生聚丙烯用於分配應用;並與Sonmol合作開發針對呼吸系統和其他疾病的數字療法和服務平台。艾博集團公司成立於1992年,總部位於伊利諾伊州水晶湖。
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
警語
1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。
2. 資料並不完整,需要完整資料請至相關網站索取。
3. 任何股市數據分析皆存在倖存者偏差。